Select Medical Holdings (SEM) Receivables (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Receivables data on file, last reported at $949.5 million in Q1 2026.

• Quarterly Receivables rose 4.55% year-over-year to $949.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $949.5 million (up 4.55% YoY) and the FY2025 annual result came in at $864.2 million, up 5.21% from the prior year.
• Receivables climbed to $949.5 million in Q1 2026 per SEM's latest filing, from $864.2 million in the prior quarter.
• Across five years, Receivables topped out at $1.1 billion in Q1 2024 and bottomed at $724.1 million in Q4 2023.
• The 5-year median for Receivables is $941.4 million (2022), against an average of $936.0 million.
• The widest annual swing landed in 2023, when Receivables slipped 24.38%; it then climbed 13.79% in 2024.
• Tracing SEM's Receivables over 5 years: stood at $957.6 million in 2022, then fell by 24.38% to $724.1 million in 2023, then grew by 13.43% to $821.4 million in 2024, then increased by 5.21% to $864.2 million in 2025, then rose by 9.87% to $949.5 million in 2026.
• Per Business Quant, the three latest SEM Receivables figures stand at $949.5 million (Q1 2026), $864.2 million (Q4 2025), and $825.8 million (Q3 2025).

Peer Comparison